Most cited papers from Aradigm (United States)
What are the most cited papers from Aradigm (United States)?
The most cited paper from Aradigm (United States) is "Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial" (David J. Serisier, Diana Bilton, Anthony De Soyza et al., 2013), with 250 citations. Next come "Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system☆" (225) and "Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials" (214).
Showing 50 of 60 papers. Every paper with more than 18 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial David J. Serisier, Diana Bilton, Anthony De Soyza et al. · Thorax | 16 May 2013 | 250 |
| 2 | Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system☆ Pradipta Chattopadhyay, Boris Yu Shekunov, DaBin Yim et al. · Advanced Drug Delivery Reviews | 24 May 2007 | 225 |
| 3 | Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials Charles Haworth, Diana Bilton, James Duncan Chalmers et al. · The Lancet Respiratory Medicine | 15 Jan 2019 | 214 |
| 4 | Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects Evangelia Daviskas, Sandra D. Anderson, Igor Gonda et al. · European Respiratory Journal | Apr 1996 | 186 |
| 5 | Development of Liposomal Ciprofloxacin to Treat Lung Infections David C. Cipolla, Jim Blanchard, Igor Gonda · Pharmaceutics | Mar 2016 | 176 |
| 6 | Drug nanocrystallisation within liposomes Li Tang, David C. Cipolla, Thomas Rades et al. · Journal of Controlled Release | 2 Sep 2018 | 155 |
| 7 | Liposomal Formulations for Inhalation David C. Cipolla, Igor Gonda, Hak‐Kim Chan · Therapeutic Delivery | Aug 2013 | 155 |
| 8 | Pharmacokinetics and Pharmacodynamics of Inhaled versus Intravenous Morphine in Healthy Volunteers Mark Dershwitz, John L. Walsh, Richard J. Morishige et al. · Anesthesiology | Sep 2000 | 141 |
| 9 | Spray Dried Powders and Powder Blends of Recombinant Human Deoxyribonuclease (rhDNase) for Aerosol Delivery Hak‐Kim Chan, Andy Clark, Igor Gonda et al. · Pharmaceutical Research | Apr 1997 | 141 |
| 10 | Lipid-based carriers for pulmonary products: Preclinical development and case studies in humans David C. Cipolla, Boris Yu Shekunov, Jim Blanchard et al. · Advanced Drug Delivery Reviews | 10 May 2014 | 123 |
| 11 | Pulmonary administration of aerosolised fentanyl: pharmacokinetic analysis of systemic delivery Laurence E. Mather, Annie Woodhouse, Marcy Ward et al. · British Journal of Clinical Pharmacology | Jul 1998 | 110 |
| 12 | Pulmonary Formulations: What Remains to be Done? Jeffry G. Weers, John Bell, Hak‐Kim Chan et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery | Dec 2010 | 106 |
| 13 | Dose-response relation of liquid aerosol inhaled insulin in Type I diabetic patients Gernot A Brunner, B. Balent, Martin Ellmerer et al. · Diabetologia | 9 Mar 2001 | 102 |
| 14 | The Ascent of Pulmonary Drug Delivery Igor Gonda · Journal of Pharmaceutical Sciences | Jul 2000 | 97 |
| 15 | Limits on the Peculiar Velocities of Two Distant Clusters Using the Kinematic Sunyaev‐Zeldovich Effect W. L. Holzapfel, Peter A. R. Ade, S. Church et al. · The Astrophysical Journal | 20 May 1997 | 89 |
| 16 | Measurement of the Hubble Constant from X‐Ray and 2.1 Millimeter Observations of Abell 2163 W. L. Holzapfel, M. Arnaud, Peter A. R. Ade et al. · The Astrophysical Journal | 10 May 1997 | 88 |
| 17 | The AERX™ Aerosol Delivery System Jeff Schuster, Reid Rubsamen, Peter M. Lloyd et al. · Pharmaceutical Research | Mar 1997 | 81 |
| 18 | Liposomal Nanoparticles Control the Uptake of Ciprofloxacin Across Respiratory Epithelia Hui Xin Ong, Daniela Traini, David C. Cipolla et al. · Pharmaceutical Research | 25 Jul 2012 | 80 |
| 19 | Modifying the Release Properties of Liposomes Toward Personalized Medicine David C. Cipolla, Huiying Wu, Igor Gonda et al. · Journal of Pharmaceutical Sciences | 8 Apr 2014 | 73 |
| 20 | Ciprofloxacin nanocrystals liposomal powders for controlled drug release via inhalation Isra Khatib, Dipesh Khanal, Juanfang Ruan et al. · International Journal of Pharmaceutics | 14 Jun 2019 | 72 |
| 21 | Development of Safety Qualification Thresholds and Their Use in Orally Inhaled and Nasal Drug Product Evaluation Douglas J. Ball, Juliette Blanchard, David Jacobson‐Kram et al. · Toxicological Sciences | 18 Jan 2007 | 72 |
| 22 | Pulmonary Insulin Administration Using the AERx® System: Physiological and Physicochemical Factors Influencing Insulin Effectiveness in Healthy Fasting Subjects Stephen J. Farr, A. McElduff, Laurence E. Mather et al. · Diabetes Technology & Therapeutics | Jun 2000 | 71 |
| 23 | Symposium Summary Jeffrey S. Tepper, Philip J. Kuehl, Stuart Cracknell et al. · International Journal of Toxicology | 7 Feb 2016 | 65 |
| 24 | Analgesic Efficacy of Inhaled Morphine in Patients after Bunionectomy Surgery John Thipphawong, Najib Babul, Richard J. Morishige et al. · Anesthesiology | Sep 2003 | 65 |
| 25 | Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system* Marcy Ward, A Woodhouse, Laurence E. Mather et al. · Clinical Pharmacology & Therapeutics | Dec 1997 | 64 |
| 26 | Development and Characterization of an In Vitro Release Assay for Liposomal Ciprofloxacin for Inhalation David C. Cipolla, Huiying Wu, Simon J. Eastman et al. · Journal of Pharmaceutical Sciences | 26 Nov 2013 | 60 |
| 27 | Inhaled Antibiotics to Treat Lung Infection David C. Cipolla, Hak‐Kim Chan · Pharmaceutical Patent Analyst | 22 Aug 2013 | 57 |
| 28 | Formulation technology to repurpose drugs for inhalation delivery David C. Cipolla, Igor Gonda · Drug Discovery Today Therapeutic Strategies | 22 Aug 2011 | 56 |
| 29 | Equivalence Considerations for Orally Inhaled Products for Local Action—ISAM/IPAC-RS European Workshop Report Carole D. Evans et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery | 13 Mar 2012 | 56 |
| 30 | In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation Hui Xin Ong, Faiza Benaouda, Daniela Traini et al. · European Journal of Pharmaceutics and Biopharmaceutics | 10 Jul 2013 | 54 |
| 31 | Deposition, Imaging, and Clearance: What Remains to be Done? G. Scheuch, William D. Bennett, Lars Borgström et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery | Dec 2010 | 54 |
| 32 | Pulmonary delivery of opioids as pain therapeutics Stephen J. Farr, Babatunde Otulana · Advanced Drug Delivery Reviews | 13 Aug 2006 | 54 |
| 33 | Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies James Duncan Chalmers, David C. Cipolla, Bruce Thompson et al. · European Respiratory Journal | 18 Jun 2020 | 52 |
| 34 | Comparison of in vitro and in vivo efficiencies of a novel unit-dose liquid aerosol generator and a pressurized metered dose inhaler Stephen J. Farr, Simon Warren, Peter M. Lloyd et al. · International Journal of Pharmaceutics | Mar 2000 | 52 |
| 35 | The Sunyaev‐Zeldovich Infrared Experiment: A Millimeter‐Wave Receiver for Cluster Cosmology W. L. Holzapfel, T. M. Wilbanks, Peter A. R. Ade et al. · The Astrophysical Journal | 10 Apr 1997 | 52 |
| 36 | Formation of drug nanocrystals under nanoconfinement afforded by liposomes David C. Cipolla, Hung‐Jen Wu, Stefan Salentinig et al. · RSC Advances | 2016 | 48 |
| 37 | An Upper Limit to Arcminute‐Scale Anisotropy in the Cosmic Microwave Background Radiation at 142 GHz S. E. Church, K. M. Ganga, P. A. R. Ade et al. · The Astrophysical Journal | Aug 1997 | 48 |
| 38 | Pharmacokinetics and Acute Safety of Inhaled Testosterone in Postmenopausal Women Sonia L. Davison, John Thipphawong, Jim Blanchard et al. · The Journal of Clinical Pharmacology | 12 Jan 2005 | 40 |
| 39 | Inhalation delivery systems with compliance and disease management capabilities Igor Gonda, Jeff Schuster, Reid Rubsamen et al. · Journal of Controlled Release | Apr 1998 | 40 |
| 40 | Personalizing Aerosol Medicine: Development of Delivery Systems Tailored to the Individual David C. Cipolla, Hak‐Kim Chan, Julius Schuster et al. · Therapeutic Delivery | Nov 2010 | 39 |
| 41 | Effective Treatment of Mycobacterium avium subsp. hominissuis and Mycobacterium abscessus Species Infections in Macrophages, Biofilm, and Mice by Using Liposomal Ciprofloxacin James D. Blanchard, Valerie D. Elias, David C. Cipolla et al. · Antimicrobial Agents and Chemotherapy | 17 Jul 2018 | 36 |
| 42 | Aerosolization of lipoplexes using AERx® pulmonary delivery system Deepa Deshpande, James D. Blanchard, Sudarshan Srinivasan et al. · AAPS PharmSci | Sep 2002 | 36 |
| 43 | The potential of liposome–encapsulated ciprofloxacin as a tularemia therapy Karleigh A. Hamblin, Jonathan P. Wong, James D. Blanchard et al. · Frontiers in Cellular and Infection Microbiology | 18 Jun 2014 | 33 |
| 44 | An Upper Limit to Arcminute Scale Anisotropy in the Cosmic Microwave Background Radiation at 142 GHz S. Church, Ken M. Ganga, Peter A. R. Ade et al. | 1997 | 32 |
| 45 | Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague Karleigh A. Hamblin, Stuart J. Armstrong, Kay B. Barnes et al. · Frontiers in Microbiology | 6 Feb 2017 | 32 |
| 46 | Liposome Encapsulation of Ciprofloxacin Improves Protection against Highly Virulent Francisella tularensis Strain Schu S4 Karleigh A. Hamblin, Stuart J. Armstrong, Kay B. Barnes et al. · Antimicrobial Agents and Chemotherapy | 17 Mar 2014 | 32 |
| 47 | Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals David C. Cipolla, Huiying Wu, Igor Gonda et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery | 15 Oct 2015 | 31 |
| 48 | Efficacy of Liposome-Encapsulated Ciprofloxacin in a Murine Model of Q Fever Isobel H. Norville, Graham J. Hatch, Kevin R. Bewley et al. · Antimicrobial Agents and Chemotherapy | 8 Jul 2014 | 31 |
| 49 | Pulmonary Insulin Administration Using the AERx ® Insulin Diabetes System John Thipphawong, Babatunde Otulana, Per Clauson et al. · Diabetes Technology & Therapeutics | Aug 2002 | 28 |
| 50 | Investigation of Protein-Surfactant Interactions by Analytical Ultracentrifugation and Electron Paramagnetic Resonance: The Use of Recombinant Human Tissue Factor as an Example LaToya S. Jones, David C. Cipolla, Jun Liu et al. · Pharmaceutical Research | Jun 1999 | 28 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.